A closed-loop approach to antiretroviral therapies for HIV infection

Abstract Antiretroviral therapies allowing for regular medical intervention in an optimal feedback role are substantiated. Individual therapies are evaluated from a multi-objective cost perspective, under different time and history constrains. The dynamics of the control system is governed by three state variables: healthy T-cells, infected T-cells, and viral particles. The drug dose administrated to the patient is taken as the manipulated or control variable. Illustrations of the methodology employed are provided for a fixed time-horizon of 180 days and variable prescription intervals, inverse discount factors, state discretization, and thresholds. Two cases are discussed: (i) beginning of the infection and (ii) near endemic equilibrium. Both open-loop and closed-loop results are presented. Dynamic Programming has been employed in the numerical treatment of the problem. Safety recommendations are also designed to cope with the chaotic behavior of the free dynamics’ flow in critical regions of the states’ domain. A software package is envisioned to assist physicians in assessing the patient “state”, estimating antiretroviral dose prescriptions for the whole treatment period, simulating the patient’s evolution, eventually correcting the original sequence in presence of incoming data, and evaluating combined costs of alternative treatment strategies.

[1]  Shuzhi Sam Ge,et al.  Nonlinear control of a dynamic model of HIV-1 , 2005, IEEE Transactions on Biomedical Engineering.

[2]  Denise E. Kirschner,et al.  Using Mathematics to Understand HIV Immune Dynamics , 1997 .

[3]  A S Perelson,et al.  Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.

[4]  J. Lange,et al.  Treatment of HIV Infection , 1996, Drug safety.

[5]  J. M. Lemos,et al.  NONLINEAR CONTROL OF HIV-1 INFECTION WITH A SINGULAR PERTURBATION MODEL , 2006 .

[6]  M. Nowak,et al.  Virus dynamics: Mathematical principles of immunology and virology , 2001 .

[7]  R M May,et al.  AIDS pathogenesis: mathematical models of HIV and SIV infections. , 1992 .

[8]  J. J. Henning,et al.  Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.

[9]  Shigui Ruan,et al.  Mathematical Biology Digital Object Identifier (DOI): , 2000 .

[10]  D. Kirschner,et al.  Optimal control of the chemotherapy of HIV , 1997, Journal of mathematical biology.

[11]  Arthur E. Bryson,et al.  Applied Optimal Control , 1969 .

[12]  D. Bangsberg,et al.  Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. , 2004, The Journal of antimicrobial chemotherapy.

[13]  Guanrong Chen,et al.  Feedback control of a biodynamical model of HIV-1 , 2001, IEEE Transactions on Biomedical Engineering.

[14]  Chung Choo Chung,et al.  Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability , 2006, 2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601).

[15]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[16]  Praphan Phanuphak,et al.  Efficacy and tolerability of 10-day monotherapy with apricitabine in antiretroviral-naive, HIV-infected patients , 2006, AIDS.

[17]  F. Menezes Campello de Souza,et al.  Modeling the dynamics of HIV-1 and CD4 and CD8 lymphocytes , 1999 .

[18]  Eduardo D. Sontag,et al.  Mathematical Control Theory Second Edition , 1998 .

[19]  A. Perelson,et al.  Dynamics of HIV infection of CD4+ T cells. , 1993, Mathematical biosciences.

[20]  A. Chervy Méthodologie de la modélisation illustrée par une analyse critique de plusieurs modèles relatifs à un procédé de production d'antibiotique , 1985 .

[21]  Claude H. Moog,et al.  Modeling of the HIV/AIDS Infection: An Aid for an Early Diagnosis of Patients , 2007 .

[22]  Xiaohua Xia,et al.  When to initiate HIV therapy: a control theoretic approach , 2003, IEEE Transactions on Biomedical Engineering.

[23]  José Álvarez-Ramírez,et al.  Feedback Control of the chemotherapy of HIV , 2000, Int. J. Bifurc. Chaos.

[24]  R. Lempicki,et al.  HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M A Nowak,et al.  Mathematical biology of HIV infections: antigenic variation and diversity threshold. , 1991, Mathematical biosciences.

[26]  Eduardo D. Sontag,et al.  Mathematical Control Theory: Deterministic Finite Dimensional Systems , 1990 .